Carmat Cash Flow Conversion Efficiency
Carmat cash flow conversion efficiency. Based on the latest financial reports, Carmat (ALCAR) has a cash flow conversion efficiency ratio of 0.344x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-17.58 Million ≈ $-20.56 Million USD) by net assets (€-51.13 Million ≈ $-59.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Carmat (2010–2024)
Cash flow conversion efficiency of Carmat from 2010 to 2024. This chart illustrates how Carmat's cash flow conversion efficiency has evolved over time, based on yearly financial data. View ALCAR live share price for real-time trading data and today's change.
Carmat Cash Flow Conversion Ratio Explained
Carmat cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Carmat Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Carmat ranked by their cash flow conversion efficiency. Also see Carmat market cap and net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Noble Financials SA
WAR:IBS
|
0.010x |
|
Canadian Premium Sand Inc
V:CPS
|
0.086x |
|
Domec Compania de Artefactos Domesticos SAIC y F
BA:DOME
|
-0.048x |
|
Au Gold Corp
V:AUGC
|
-0.028x |
|
Gema Grahasarana Tbk
JK:GEMA
|
-0.034x |
|
Prakash Steelage Limited
NSE:PRAKASHSTL
|
0.505x |
|
RECYCLICO BATTERY METALS
F:ID4
|
-0.015x |
|
Curative Biotechnology Inc
NYSE MKT:CUBT
|
0.031x |
Annual Cash Flow Conversion Efficiency for Carmat (2010–2024)
The table below shows the annual cash flow conversion efficiency of Carmat from 2010 to 2024. Review Carmat (ALCAR) flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-51.13 Million ≈ $-59.78 Million |
€-43.31 Million ≈ $-50.64 Million |
0.847x | -30.68% |
| 2023-12-31 | €-43.76 Million ≈ $-51.16 Million |
€-53.48 Million ≈ $-62.52 Million |
1.222x | +104.05% |
| 2022-12-31 | €1.80 Million ≈ $2.11 Million |
€-54.38 Million ≈ $-63.57 Million |
-30.175x | -788.21% |
| 2021-12-31 | €-13.72 Million ≈ $-16.04 Million |
€-60.17 Million ≈ $-70.34 Million |
4.385x | +179.66% |
| 2020-12-31 | €7.82 Million ≈ $9.14 Million |
€-43.03 Million ≈ $-50.31 Million |
-5.504x | -232.89% |
| 2019-12-31 | €24.34 Million ≈ $28.46 Million |
€-40.24 Million ≈ $-47.05 Million |
-1.653x | +11.04% |
| 2018-12-31 | €20.54 Million ≈ $24.01 Million |
€-38.17 Million ≈ $-44.63 Million |
-1.859x | -337.96% |
| 2017-12-31 | €57.21 Million ≈ $66.88 Million |
€-24.28 Million ≈ $-28.38 Million |
-0.424x | +42.37% |
| 2016-12-31 | €28.89 Million ≈ $33.77 Million |
€-21.27 Million ≈ $-24.87 Million |
-0.736x | +93.99% |
| 2015-12-31 | €1.40 Million ≈ $1.64 Million |
€-17.19 Million ≈ $-20.09 Million |
-12.248x | -407.32% |
| 2014-12-31 | €7.76 Million ≈ $9.08 Million |
€-18.75 Million ≈ $-21.92 Million |
-2.414x | -81.08% |
| 2013-12-31 | €7.23 Million ≈ $8.45 Million |
€-9.64 Million ≈ $-11.27 Million |
-1.333x | +26.17% |
| 2012-12-31 | €9.94 Million ≈ $11.62 Million |
€-17.95 Million ≈ $-20.99 Million |
-1.806x | -400.34% |
| 2011-12-31 | €26.89 Million ≈ $31.44 Million |
€-9.71 Million ≈ $-11.35 Million |
-0.361x | +19.55% |
| 2010-12-31 | €15.49 Million ≈ $18.11 Million |
€-6.95 Million ≈ $-8.13 Million |
-0.449x | -- |
About Carmat
Carmat SA designs and develops total artificial heart for patients with advanced heart failure in France and internationally. The company offers Aeson, an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The company was incorporated in 2008 and is headquartered in Vélizy-Villacoublay, France.